Human Coagulation Factor Viii, Human Von Willebrand Factor

2 trials 2 recruiting BHaematology

Filter these 2 trials by condition, phase, country and more.

Open in Search →

2 Registered trials

2 Recruiting

0 Completed trials

3 Sponsors

12 Countries

Phase III

Phase IV

Phase III: 1 Phase IV: 1

Indications tested

Von Willebrand´s disease 1

Sponsors using this IMP

Emory University 1 F. Hoffmann-La Roche AG 1 HZRM Haemophilie-Zentrum Rhein Main GmbH 1

All trials

2 total

A Study to assess safety and effectiveness of Emicizumab in Patients with Type 3 Von Willebrand Disease Recruiting

2024-515622-80-00 Phase III 8 countries F. Hoffmann-La Roche AG
An international investigator initiated trial to capture different approaches in the treatment of Haemophilia A Patients With FVIII Inhibito… Recruiting

2024-516741-39-00 Phase IV 7 countries Emory University; HZRM Haemophilie-Zentrum Rhein Main GmbH

Showing 1–2 of 2 trials

← All drugs A–Z